Buscar
27/01/2026
Real-world experience with belimumab-based triple therapy in proliferative lupus nephritis: data from the BEL-SPAIN Registry
Vidal-Montal, P, Fabregat, A, Altabás-González, I, Pego-Reigosa, JM, Hernández-Martínez, A, Rua-Figueroa, I, Salman-Monte, T, Moriano, C, Segura, BT, Vela, P, Pareja-Martínez, A, García-Cirera, S, García-Villanueva, MJ, Garrote-Corral, S, Heredia, S, Riancho-Zarrabeitia, L, Manrique-Arija, S, Bernárdez, J, Magallares, B, Torrente-Segarra, V, Frade-Sosa, B, Gómez-Puerta, JA, Martinez-Barrio, J, Narvaez, J. Real-world experience with belimumab-based triple therapy in proliferative lupus nephritis: data from the BEL-SPAIN Registry. Lupus Science & Medicine. 2026; 13(1)DOI:10.1136/lupus-2025-001825. PMID:41592907. IF:3.500(Q2/3D).
27/01/2026
Immune and Endothelial-Related Extracellular Vesicles Are Associated with Corticosteroid Response and Mortality in Alcohol-Associated Hepatitis
Guinart-Cuadra, A, Brujats, A, Szafranska, J, Guerrero, R, Dinamarca, F, Cantó, E, Poca, M, Román, E, Sánchez-Ardid, E, Fajardo, J, Camps, M, Mulet, M, Soriano, G, Escorsell, A, Falcon-Perez, JM, Gonzalez, E, Ferrero-Gregori, A, Gely, C, Villalba, J, Bataller, R, Argemi, J, Osuna-Gómez, R, Vidal, S, Alvarado-Tapias, E. Immune and Endothelial-Related Extracellular Vesicles Are Associated with Corticosteroid Response and Mortality in Alcohol-Associated Hepatitis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2026; 27(3)DOI:10.3390/ijms27031258. PMID:41683683. IF:4.900(Q1/3D).
25/01/2026
In vivo inhibition of miR-125b-5p modulates monocyte trafficking through the CCR7 receptor and reduces atherosclerosis
Mallén, A, Rotllan, N, Griñán, R, Varela, C, Bertolino, E, Paloschi, V, Maegdefessel, L, Escolà-Gil, JC, Aran, JM, Sbraga, F, Blasco-Lucas, A, Torras, J, Navarro, E, Hueso, M. In vivo inhibition of miR-125b-5p modulates monocyte trafficking through the CCR7 receptor and reduces atherosclerosis. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY. 2026; 330(1)DOI:10.1152/ajpcell.00242.2025. PMID:41289597. IF:4.700(Q1/1D).
25/01/2026
Effects of immersive virtual reality and adaptive cognitive training on cognition and function in parkinson's disease mild cognitive impairment: a randomized clinical trial
Puig-Davi, A, Moreu-Valls, A, Aracil-Bolaños, I, Fernandez-Cocaño, A, Rodríguez-Antigüedad, J, Kulisevsky, G, Horta-Barba, A, Pagonabarraga, J, Kulisevsky, J, Martinez-Horta, S. Effects of immersive virtual reality and adaptive cognitive training on cognition and function in parkinson's disease mild cognitive impairment: a randomized clinical trial. Scientific Reports. 2026; 16(1)DOI:10.1038/s41598-025-31833-1. PMID:41582160. IF:3.900(Q1/2D).